You cannot select more than 25 topics
Topics must start with a letter or number, can include dashes ('-') and can be up to 35 characters long.
175 lines
87 KiB
XML
175 lines
87 KiB
XML
<?xml version="1.0" encoding="UTF-8"?>
|
|
<class-scheme publication-date="2023-02-01" scheme-type="cpc" publication-type="official">
|
|
<classification-item breakdown-code="false" not-allocatable="true" level="5" additional-only="false" sort-key="A61P" definition-exists="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS</text></title-part></class-title><notes-and-warnings><note type="note"><note-paragraph>This subclass <u>covers</u> therapeutic activity of chemical compounds or medicinal preparations already classified as such in subclasses <class-ref scheme="cpc">A61K</class-ref> or <class-ref scheme="cpc">C12N</class-ref>, or in classes <class-ref scheme="cpc">C01</class-ref>, <class-ref scheme="cpc">C07</class-ref> or <class-ref scheme="cpc">C08</class-ref></note-paragraph><note-paragraph>In this subclass, the term "drugs" includes chemical compounds or compositions with therapeutic activity.</note-paragraph><note-paragraph>In this subclass, therapeutic activity is classified in all appropriate places <CPC-specific-note>to the extent of all the different therapeutic activities stated in the claims and also significantly disclosed as examples in the disclosure</CPC-specific-note>.</note-paragraph><note-paragraph>Attention is drawn to cases where the subject of the invention concerns only specific therapeutic activity of chemical compounds or medical preparations, and the chemical structure, compound, mixture or composition of this subject of the invention is known. In such cases, classification is made in both subclass <class-ref scheme="cpc">A61K</class-ref> and subclass <class-ref scheme="cpc">A61P</class-ref> as invention information. In addition, if the chemical structure, compound, mixture or composition or any individual ingredient of a mixture or composition is considered to represent information of interest for search, it may also be classified as additional information. <CPC-specific-note>There is no classification in <class-ref scheme="cpc">C01</class-ref>, <class-ref scheme="cpc">C07</class-ref>, <class-ref scheme="cpc">C08</class-ref>, <class-ref scheme="cpc">C12N</class-ref> as additional information in CPC if the chemical structure, compound, mixture or composition or any individual ingredient of a mixture or composition is known and classification is made in both subclass <class-ref scheme="cpc">A61K</class-ref> and subclass <class-ref scheme="cpc">A61P</class-ref> as invention information.</CPC-specific-note></note-paragraph><note-paragraph>The classification symbols of this subclass are not listed first when assigned to patent documents.</note-paragraph></note></notes-and-warnings>
|
|
<classification-item breakdown-code="false" not-allocatable="true" level="6" additional-only="false" sort-key="A61P1/00" date-revised="2018-01-01" status="published"><classification-symbol>A61P1/00</classification-symbol>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="7" additional-only="false" sort-key="A61P1/00" definition-exists="true" ipc-concordant="A61P1/00" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P1/00</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Drugs for disorders of the alimentary tract or the digestive system</text></title-part></class-title>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P1/02" definition-exists="false" ipc-concordant="A61P1/02" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P1/02</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P1/04" definition-exists="false" ipc-concordant="A61P1/04" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P1/04</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P1/06" definition-exists="false" ipc-concordant="A61P1/06" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P1/06</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P1/08" definition-exists="false" ipc-concordant="A61P1/08" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P1/08</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>for nausea, cinetosis or vertigo</text></title-part><title-part><text>Antiemetics</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P1/10" definition-exists="false" ipc-concordant="A61P1/10" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P1/10</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Laxatives</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P1/12" definition-exists="false" ipc-concordant="A61P1/12" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P1/12</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Antidiarrhoeals</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P1/14" definition-exists="false" ipc-concordant="A61P1/14" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P1/14</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P1/16" definition-exists="false" ipc-concordant="A61P1/16" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P1/16</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P1/18" definition-exists="false" ipc-concordant="A61P1/18" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P1/18</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>for pancreatic disorders, e.g. pancreatic enzymes</text></title-part></class-title></classification-item></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="7" additional-only="false" sort-key="A61P3/00" definition-exists="true" ipc-concordant="A61P3/00" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P3/00</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Drugs for disorders of the metabolism </text><reference><text>of the blood or the extracellular fluid <class-ref scheme="cpc">A61P7/00</class-ref></text></reference></title-part></class-title>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P3/02" definition-exists="false" ipc-concordant="A61P3/02" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P3/02</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Nutrients, e.g. vitamins, minerals</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P3/04" definition-exists="false" ipc-concordant="A61P3/04" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P3/04</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Anorexiants</text></title-part><title-part><text>Antiobesity agents</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P3/06" definition-exists="false" ipc-concordant="A61P3/06" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P3/06</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Antihyperlipidemics</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P3/08" definition-exists="false" ipc-concordant="A61P3/08" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P3/08</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>for glucose homeostasis </text><reference><text>pancreatic hormones <class-ref scheme="cpc">A61P5/48</class-ref></text></reference></title-part></class-title>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="9" additional-only="false" sort-key="A61P3/10" definition-exists="false" ipc-concordant="A61P3/10" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P3/10</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>for hyperglycaemia, e.g. antidiabetics</text></title-part></class-title></classification-item></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P3/12" definition-exists="false" ipc-concordant="A61P3/12" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P3/12</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>for electrolyte homeostasis</text></title-part></class-title>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="9" additional-only="false" sort-key="A61P3/14" definition-exists="false" ipc-concordant="A61P3/14" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P3/14</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>for calcium homeostasis </text><reference><text>vitamin D <class-ref scheme="cpc">A61P3/02</class-ref>; parathyroid hormones <class-ref scheme="cpc">A61P5/18</class-ref>; calcitonin <class-ref scheme="cpc">A61P5/22</class-ref>; osteoporosis <class-ref scheme="cpc">A61P19/10</class-ref>; bone metastasis <class-ref scheme="cpc">A61P35/04</class-ref></text></reference></title-part></class-title></classification-item></classification-item></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="7" additional-only="false" sort-key="A61P5/00" definition-exists="true" ipc-concordant="A61P5/00" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P5/00</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Drugs for disorders of the endocrine system</text></title-part></class-title>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P5/02" definition-exists="false" ipc-concordant="A61P5/02" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P5/02</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin</text></title-part></class-title>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="9" additional-only="false" sort-key="A61P5/04" definition-exists="false" ipc-concordant="A61P5/04" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P5/04</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>for decreasing, blocking or antagonising the activity of the hypothalamic hormones</text></title-part></class-title></classification-item></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P5/06" definition-exists="false" ipc-concordant="A61P5/06" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P5/06</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH</text></title-part></class-title>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="9" additional-only="false" sort-key="A61P5/08" definition-exists="false" ipc-concordant="A61P5/08" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P5/08</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>for decreasing, blocking or antagonising the activity of the anterior pituitary hormones</text></title-part></class-title></classification-item></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P5/10" definition-exists="false" ipc-concordant="A61P5/10" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P5/10</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>of the posterior pituitary hormones, e.g. oxytocin, ADH</text></title-part></class-title>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="9" additional-only="false" sort-key="A61P5/12" definition-exists="false" ipc-concordant="A61P5/12" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P5/12</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>for decreasing, blocking or antagonising the activity of the posterior pituitary hormones</text></title-part></class-title></classification-item></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P5/14" definition-exists="false" ipc-concordant="A61P5/14" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P5/14</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>of the thyroid hormones, e.g. T3, T4</text></title-part></class-title>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="9" additional-only="false" sort-key="A61P5/16" definition-exists="false" ipc-concordant="A61P5/16" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P5/16</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>for decreasing, blocking or antagonising the activity of the thyroid hormones</text></title-part></class-title></classification-item></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P5/18" definition-exists="false" ipc-concordant="A61P5/18" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P5/18</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>of the parathyroid hormones</text></title-part></class-title>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="9" additional-only="false" sort-key="A61P5/20" definition-exists="false" ipc-concordant="A61P5/20" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P5/20</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>for decreasing, blocking or antagonising the activity of PTH</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="9" additional-only="false" sort-key="A61P5/22" definition-exists="false" ipc-concordant="A61P5/22" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P5/22</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>for decreasing, blocking or antagonising the activity of calcitonin</text></title-part></class-title></classification-item></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P5/24" definition-exists="false" ipc-concordant="A61P5/24" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P5/24</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>of the sex hormones</text></title-part></class-title>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="9" additional-only="false" sort-key="A61P5/26" definition-exists="false" ipc-concordant="A61P5/26" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P5/26</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Androgens</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="9" additional-only="false" sort-key="A61P5/28" definition-exists="false" ipc-concordant="A61P5/28" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P5/28</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Antiandrogens</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="9" additional-only="false" sort-key="A61P5/30" definition-exists="false" ipc-concordant="A61P5/30" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P5/30</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Oestrogens</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="9" additional-only="false" sort-key="A61P5/32" definition-exists="false" ipc-concordant="A61P5/32" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P5/32</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Antioestrogens</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="9" additional-only="false" sort-key="A61P5/34" definition-exists="false" ipc-concordant="A61P5/34" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P5/34</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Gestagens</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="9" additional-only="false" sort-key="A61P5/36" definition-exists="false" ipc-concordant="A61P5/36" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P5/36</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Antigestagens</text></title-part></class-title></classification-item></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P5/38" definition-exists="false" ipc-concordant="A61P5/38" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P5/38</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>of the suprarenal hormones</text></title-part></class-title>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="9" additional-only="false" sort-key="A61P5/40" definition-exists="false" ipc-concordant="A61P5/40" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P5/40</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Mineralocorticosteroids, e.g. aldosterone</text></title-part><title-part><text>Drugs increasing or potentiating the activity of mineralocorticosteroids</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="9" additional-only="false" sort-key="A61P5/42" definition-exists="false" ipc-concordant="A61P5/42" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P5/42</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>for decreasing, blocking or antagonising the activity of mineralocorticosteroids</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="9" additional-only="false" sort-key="A61P5/44" definition-exists="false" ipc-concordant="A61P5/44" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P5/44</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Glucocorticosteroids</text></title-part><title-part><text>Drugs increasing or potentiating the activity of glucocorticosteroids</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="9" additional-only="false" sort-key="A61P5/46" definition-exists="false" ipc-concordant="A61P5/46" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P5/46</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>for decreasing, blocking or antagonising the activity of glucocorticosteroids</text></title-part></class-title></classification-item></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P5/48" definition-exists="false" ipc-concordant="A61P5/48" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P5/48</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>of the pancreatic hormones</text></title-part></class-title>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="9" additional-only="false" sort-key="A61P5/50" definition-exists="false" ipc-concordant="A61P5/50" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P5/50</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>for increasing or potentiating the activity of insulin</text></title-part></class-title></classification-item></classification-item></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="7" additional-only="false" sort-key="A61P7/00" definition-exists="true" ipc-concordant="A61P7/00" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P7/00</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Drugs for disorders of the blood or the extracellular fluid</text></title-part></class-title>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P7/02" definition-exists="false" ipc-concordant="A61P7/02" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P7/02</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Antithrombotic agents</text></title-part><title-part><text>Anticoagulants</text></title-part><title-part><text>Platelet aggregation inhibitors</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P7/04" definition-exists="false" ipc-concordant="A61P7/04" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2021-02-01" status="published"><classification-symbol>A61P7/04</classification-symbol><class-title date-revised="2021-02-01"><title-part><text>Antihaemorrhagics</text></title-part><title-part><text>Procoagulants</text></title-part><title-part><text>Haemostatic agents</text></title-part><title-part><text>Antifibrinolytic agents</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P7/06" definition-exists="false" ipc-concordant="A61P7/06" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P7/06</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Antianaemics</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P7/08" definition-exists="false" ipc-concordant="A61P7/08" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P7/08</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Plasma substitutes</text></title-part><title-part><text>Perfusion solutions</text></title-part><title-part><text>Dialytics or haemodialytics</text></title-part><title-part><text>Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock </text><reference><text>artificial tears <class-ref scheme="cpc">A61P27/04</class-ref></text></reference></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P7/10" definition-exists="false" ipc-concordant="A61P7/10" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P7/10</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Antioedematous agents</text></title-part><title-part><text>Diuretics</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P7/12" definition-exists="false" ipc-concordant="A61P7/12" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P7/12</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Antidiuretics, e.g. drugs for diabetes insipidus </text><reference><text>ADH <class-ref scheme="cpc">A61P5/10</class-ref></text></reference></title-part></class-title></classification-item></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="7" additional-only="false" sort-key="A61P9/00" definition-exists="true" ipc-concordant="A61P9/00" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P9/00</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Drugs for disorders of the cardiovascular system</text></title-part></class-title>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P9/02" definition-exists="false" ipc-concordant="A61P9/02" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P9/02</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P9/04" definition-exists="false" ipc-concordant="A61P9/04" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P9/04</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Inotropic agents, i.e. stimulants of cardiac contraction</text></title-part><title-part><text>Drugs for heart failure</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P9/06" definition-exists="false" ipc-concordant="A61P9/06" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P9/06</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Antiarrhythmics</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P9/08" definition-exists="false" ipc-concordant="A61P9/08" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P9/08</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Vasodilators for multiple indications</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P9/10" definition-exists="false" ipc-concordant="A61P9/10" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P9/10</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P9/12" definition-exists="false" ipc-concordant="A61P9/12" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P9/12</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Antihypertensives</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P9/14" definition-exists="false" ipc-concordant="A61P9/14" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P9/14</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Vasoprotectives</text></title-part><title-part><text>Antihaemorrhoidals</text></title-part><title-part><text>Drugs for varicose therapy</text></title-part><title-part><text>Capillary stabilisers</text></title-part></class-title></classification-item></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="7" additional-only="false" sort-key="A61P11/00" definition-exists="true" ipc-concordant="A61P11/00" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P11/00</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Drugs for disorders of the respiratory system</text></title-part></class-title>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P11/02" definition-exists="false" ipc-concordant="A61P11/02" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P11/02</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Nasal agents, e.g. decongestants</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P11/04" definition-exists="false" ipc-concordant="A61P11/04" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P11/04</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>for throat disorders</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P11/06" definition-exists="false" ipc-concordant="A61P11/06" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P11/06</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Antiasthmatics</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P11/08" definition-exists="false" ipc-concordant="A61P11/08" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P11/08</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Bronchodilators</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P11/10" definition-exists="false" ipc-concordant="A61P11/10" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P11/10</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Expectorants</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P11/12" definition-exists="false" ipc-concordant="A61P11/12" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P11/12</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Mucolytics</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P11/14" definition-exists="false" ipc-concordant="A61P11/14" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P11/14</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Antitussive agents</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P11/16" definition-exists="false" ipc-concordant="A61P11/16" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P11/16</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Central respiratory analeptics</text></title-part></class-title></classification-item></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="7" additional-only="false" sort-key="A61P13/00" definition-exists="true" ipc-concordant="A61P13/00" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P13/00</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Drugs for disorders of the urinary system</text></title-part></class-title>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P13/02" definition-exists="false" ipc-concordant="A61P13/02" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P13/02</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>of urine or of the urinary tract, e.g. urine acidifiers</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P13/04" definition-exists="false" ipc-concordant="A61P13/04" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P13/04</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>for urolithiasis</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P13/06" definition-exists="false" ipc-concordant="A61P13/06" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P13/06</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Anti-spasmodics</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P13/08" definition-exists="false" ipc-concordant="A61P13/08" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P13/08</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>of the prostate</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P13/10" definition-exists="false" ipc-concordant="A61P13/10" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P13/10</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>of the bladder</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P13/12" definition-exists="false" ipc-concordant="A61P13/12" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P13/12</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>of the kidneys</text></title-part></class-title></classification-item></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="7" additional-only="false" sort-key="A61P15/00" definition-exists="true" ipc-concordant="A61P15/00" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P15/00</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Drugs for genital or sexual disorders </text><reference><text>for disorders of sex hormones <class-ref scheme="cpc">A61P5/24</class-ref></text></reference></title-part><title-part><text>Contraceptives</text></title-part></class-title>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P15/02" definition-exists="false" ipc-concordant="A61P15/02" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P15/02</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>for disorders of the vagina</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P15/04" definition-exists="false" ipc-concordant="A61P15/04" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P15/04</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>for inducing labour or abortion</text></title-part><title-part><text>Uterotonics</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P15/06" definition-exists="false" ipc-concordant="A61P15/06" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P15/06</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Antiabortive agents</text></title-part><title-part><text>Labour repressants</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P15/08" definition-exists="false" ipc-concordant="A61P15/08" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P15/08</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P15/10" definition-exists="false" ipc-concordant="A61P15/10" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P15/10</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>for impotence</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P15/12" definition-exists="false" ipc-concordant="A61P15/12" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P15/12</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>for climacteric disorders</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P15/14" definition-exists="false" ipc-concordant="A61P15/14" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P15/14</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>for lactation disorders, e.g. galactorrhoea</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P15/16" definition-exists="false" ipc-concordant="A61P15/16" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P15/16</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Masculine contraceptives</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P15/18" definition-exists="false" ipc-concordant="A61P15/18" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P15/18</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Feminine contraceptives</text></title-part></class-title></classification-item></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="7" additional-only="false" sort-key="A61P17/00" definition-exists="true" ipc-concordant="A61P17/00" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P17/00</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Drugs for dermatological disorders</text></title-part></class-title>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P17/02" definition-exists="false" ipc-concordant="A61P17/02" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P17/02</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>for treating wounds, ulcers, burns, scars, keloids, or the like</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P17/04" definition-exists="false" ipc-concordant="A61P17/04" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P17/04</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Antipruritics</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P17/06" definition-exists="false" ipc-concordant="A61P17/06" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P17/06</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Antipsoriatics</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P17/08" definition-exists="false" ipc-concordant="A61P17/08" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P17/08</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Antiseborrheics</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P17/10" definition-exists="false" ipc-concordant="A61P17/10" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P17/10</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Anti-acne agents</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P17/12" definition-exists="false" ipc-concordant="A61P17/12" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P17/12</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Keratolytics, e.g. wart or anti-corn preparations</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P17/14" definition-exists="false" ipc-concordant="A61P17/14" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P17/14</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>for baldness or alopecia</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P17/16" definition-exists="false" ipc-concordant="A61P17/16" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P17/16</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Emollients or protectives, e.g. against radiation</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P17/18" definition-exists="false" ipc-concordant="A61P17/18" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P17/18</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Antioxidants, e.g. antiradicals </text><reference><text>preparations for protection against sunlight <class-ref scheme="cpc">A61Q17/00</class-ref></text></reference></title-part></class-title></classification-item></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="7" additional-only="false" sort-key="A61P19/00" definition-exists="true" ipc-concordant="A61P19/00" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P19/00</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Drugs for skeletal disorders</text></title-part></class-title>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P19/02" definition-exists="false" ipc-concordant="A61P19/02" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P19/02</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>for joint disorders, e.g. arthritis, arthrosis</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P19/04" definition-exists="false" ipc-concordant="A61P19/04" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P19/04</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>for non-specific disorders of the connective tissue</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P19/06" definition-exists="false" ipc-concordant="A61P19/06" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P19/06</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Antigout agents, e.g. antihyperuricemic or uricosuric agents</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P19/08" definition-exists="false" ipc-concordant="A61P19/08" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P19/08</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>for bone diseases, e.g. rachitism, Paget's disease</text></title-part></class-title>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="9" additional-only="false" sort-key="A61P19/10" definition-exists="false" ipc-concordant="A61P19/10" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P19/10</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>for osteoporosis</text></title-part></class-title></classification-item></classification-item></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="7" additional-only="false" sort-key="A61P21/00" definition-exists="true" ipc-concordant="A61P21/00" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P21/00</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Drugs for disorders of the muscular or neuromuscular system</text></title-part></class-title>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P21/02" definition-exists="false" ipc-concordant="A61P21/02" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P21/02</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Muscle relaxants, e.g. for tetanus or cramps</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P21/04" definition-exists="false" ipc-concordant="A61P21/04" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P21/04</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>for myasthenia gravis</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P21/06" definition-exists="false" ipc-concordant="A61P21/06" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P21/06</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Anabolic agents </text><reference><text>androgens <class-ref scheme="cpc">A61P5/26</class-ref></text></reference></title-part></class-title></classification-item></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="7" additional-only="false" sort-key="A61P23/00" definition-exists="true" ipc-concordant="A61P23/00" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P23/00</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Anaesthetics</text></title-part></class-title>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P23/02" definition-exists="false" ipc-concordant="A61P23/02" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P23/02</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Local anaesthetics</text></title-part></class-title></classification-item></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="7" additional-only="false" sort-key="A61P25/00" definition-exists="true" ipc-concordant="A61P25/00" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P25/00</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Drugs for disorders of the nervous system</text></title-part></class-title>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P25/02" definition-exists="false" ipc-concordant="A61P25/02" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P25/02</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>for peripheral neuropathies</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P25/04" definition-exists="false" ipc-concordant="A61P25/04" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P25/04</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Centrally acting analgesics, e.g. opioids</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P25/06" definition-exists="false" ipc-concordant="A61P25/06" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P25/06</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Antimigraine agents</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P25/08" definition-exists="false" ipc-concordant="A61P25/08" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P25/08</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Antiepileptics</text></title-part><title-part><text>Anticonvulsants</text></title-part></class-title>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="9" additional-only="false" sort-key="A61P25/10" definition-exists="false" ipc-concordant="A61P25/10" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P25/10</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>for petit-mal</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="9" additional-only="false" sort-key="A61P25/12" definition-exists="false" ipc-concordant="A61P25/12" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P25/12</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>for grand-mal</text></title-part></class-title></classification-item></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P25/14" definition-exists="false" ipc-concordant="A61P25/14" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P25/14</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>for treating abnormal movements, e.g. chorea, dyskinesia</text></title-part></class-title>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="9" additional-only="false" sort-key="A61P25/16" definition-exists="false" ipc-concordant="A61P25/16" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P25/16</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Anti-Parkinson drugs</text></title-part></class-title></classification-item></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P25/18" definition-exists="false" ipc-concordant="A61P25/18" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P25/18</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Antipsychotics, i.e. neuroleptics</text></title-part><title-part><text>Drugs for mania or schizophrenia</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P25/20" definition-exists="false" ipc-concordant="A61P25/20" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P25/20</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Hypnotics</text></title-part><title-part><text>Sedatives</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P25/22" definition-exists="false" ipc-concordant="A61P25/22" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P25/22</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Anxiolytics</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P25/24" definition-exists="false" ipc-concordant="A61P25/24" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P25/24</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Antidepressants</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P25/26" definition-exists="false" ipc-concordant="A61P25/26" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P25/26</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Psychostimulants, e.g. nicotine, cocaine</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P25/28" definition-exists="false" ipc-concordant="A61P25/28" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P25/28</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P25/30" definition-exists="false" ipc-concordant="A61P25/30" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P25/30</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>for treating abuse or dependence</text></title-part></class-title>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="9" additional-only="false" sort-key="A61P25/32" definition-exists="false" ipc-concordant="A61P25/32" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P25/32</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Alcohol-abuse</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="9" additional-only="false" sort-key="A61P25/34" definition-exists="false" ipc-concordant="A61P25/34" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P25/34</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Tobacco-abuse</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="9" additional-only="false" sort-key="A61P25/36" definition-exists="false" ipc-concordant="A61P25/36" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P25/36</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Opioid-abuse</text></title-part></class-title></classification-item></classification-item></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="7" additional-only="false" sort-key="A61P27/00" definition-exists="true" ipc-concordant="A61P27/00" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P27/00</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Drugs for disorders of the senses</text></title-part></class-title>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P27/02" definition-exists="false" ipc-concordant="A61P27/02" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P27/02</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Ophthalmic agents</text></title-part></class-title>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="9" additional-only="false" sort-key="A61P27/04" definition-exists="false" ipc-concordant="A61P27/04" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P27/04</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Artificial tears</text></title-part><title-part><text>Irrigation solutions</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="9" additional-only="false" sort-key="A61P27/06" definition-exists="false" ipc-concordant="A61P27/06" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P27/06</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Antiglaucoma agents or miotics</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="9" additional-only="false" sort-key="A61P27/08" definition-exists="false" ipc-concordant="A61P27/08" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P27/08</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Mydriatics or cycloplegics</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="9" additional-only="false" sort-key="A61P27/10" definition-exists="false" ipc-concordant="A61P27/10" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P27/10</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>for accommodation disorders, e.g. myopia</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="9" additional-only="false" sort-key="A61P27/12" definition-exists="false" ipc-concordant="A61P27/12" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P27/12</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>for cataracts</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="9" additional-only="false" sort-key="A61P27/14" definition-exists="false" ipc-concordant="A61P27/14" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P27/14</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Decongestants or antiallergics</text></title-part></class-title></classification-item></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P27/16" definition-exists="false" ipc-concordant="A61P27/16" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P27/16</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Otologicals</text></title-part></class-title></classification-item></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="7" additional-only="false" sort-key="A61P29/00" definition-exists="true" ipc-concordant="A61P29/00" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2023-02-01" status="published"><classification-symbol>A61P29/00</classification-symbol><class-title date-revised="2023-02-01"><title-part><text>Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents</text></title-part><title-part><text>Non-steroidal antiinflammatory drugs [NSAID]</text></title-part></class-title>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P29/02" definition-exists="false" ipc-concordant="A61P29/02" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P29/02</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>without antiinflammatory effect</text></title-part></class-title></classification-item></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="7" additional-only="false" sort-key="A61P31/00" definition-exists="true" ipc-concordant="A61P31/00" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P31/00</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics</text></title-part></class-title>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P31/02" definition-exists="false" ipc-concordant="A61P31/02" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P31/02</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Local antiseptics</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P31/04" definition-exists="false" ipc-concordant="A61P31/04" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P31/04</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Antibacterial agents</text></title-part></class-title>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="9" additional-only="false" sort-key="A61P31/06" definition-exists="false" ipc-concordant="A61P31/06" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P31/06</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>for tuberculosis</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="9" additional-only="false" sort-key="A61P31/08" definition-exists="false" ipc-concordant="A61P31/08" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P31/08</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>for leprosy</text></title-part></class-title></classification-item></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P31/10" definition-exists="false" ipc-concordant="A61P31/10" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P31/10</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Antimycotics</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P31/12" definition-exists="false" ipc-concordant="A61P31/12" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P31/12</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Antivirals</text></title-part></class-title>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="9" additional-only="false" sort-key="A61P31/14" definition-exists="false" ipc-concordant="A61P31/14" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P31/14</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>for RNA viruses</text></title-part></class-title>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="10" additional-only="false" sort-key="A61P31/16" definition-exists="false" ipc-concordant="A61P31/16" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P31/16</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>for influenza or rhinoviruses</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="10" additional-only="false" sort-key="A61P31/18" definition-exists="false" ipc-concordant="A61P31/18" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P31/18</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>for HIV</text></title-part></class-title></classification-item></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="9" additional-only="false" sort-key="A61P31/20" definition-exists="false" ipc-concordant="A61P31/20" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P31/20</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>for DNA viruses</text></title-part></class-title>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="10" additional-only="false" sort-key="A61P31/22" definition-exists="false" ipc-concordant="A61P31/22" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P31/22</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>for herpes viruses</text></title-part></class-title></classification-item></classification-item></classification-item></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="7" additional-only="false" sort-key="A61P33/00" definition-exists="true" ipc-concordant="A61P33/00" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P33/00</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Antiparasitic agents</text></title-part></class-title>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P33/02" definition-exists="false" ipc-concordant="A61P33/02" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P33/02</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis</text></title-part></class-title>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="9" additional-only="false" sort-key="A61P33/04" definition-exists="false" ipc-concordant="A61P33/04" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P33/04</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Amoebicides</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="9" additional-only="false" sort-key="A61P33/06" definition-exists="false" ipc-concordant="A61P33/06" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P33/06</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Antimalarials</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="9" additional-only="false" sort-key="A61P33/08" definition-exists="false" ipc-concordant="A61P33/08" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P33/08</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>for Pneumocystis carinii</text></title-part></class-title></classification-item></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P33/10" definition-exists="false" ipc-concordant="A61P33/10" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P33/10</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Anthelmintics</text></title-part></class-title>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="9" additional-only="false" sort-key="A61P33/12" definition-exists="false" ipc-concordant="A61P33/12" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P33/12</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Schistosomicides</text></title-part></class-title></classification-item></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P33/14" definition-exists="false" ipc-concordant="A61P33/14" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P33/14</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Ectoparasiticides, e.g. scabicides</text></title-part></class-title></classification-item></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="7" additional-only="false" sort-key="A61P35/00" definition-exists="true" ipc-concordant="A61P35/00" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P35/00</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Antineoplastic agents</text></title-part></class-title>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P35/02" definition-exists="false" ipc-concordant="A61P35/02" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P35/02</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>specific for leukemia</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P35/04" definition-exists="false" ipc-concordant="A61P35/04" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P35/04</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>specific for metastasis</text></title-part></class-title></classification-item></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="7" additional-only="false" sort-key="A61P37/00" definition-exists="true" ipc-concordant="A61P37/00" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P37/00</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Drugs for immunological or allergic disorders</text></title-part></class-title>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P37/02" definition-exists="false" ipc-concordant="A61P37/02" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P37/02</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Immunomodulators</text></title-part></class-title>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="9" additional-only="false" sort-key="A61P37/04" definition-exists="false" ipc-concordant="A61P37/04" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P37/04</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Immunostimulants</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="9" additional-only="false" sort-key="A61P37/06" definition-exists="false" ipc-concordant="A61P37/06" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P37/06</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Immunosuppressants, e.g. drugs for graft rejection</text></title-part></class-title></classification-item></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P37/08" definition-exists="false" ipc-concordant="A61P37/08" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P37/08</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Antiallergic agents </text><reference><text>antiasthmatic agents <class-ref scheme="cpc">A61P11/06</class-ref>; ophthalmic antiallergics <class-ref scheme="cpc">A61P27/14</class-ref></text></reference></title-part></class-title></classification-item></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="7" additional-only="false" sort-key="A61P39/00" definition-exists="true" ipc-concordant="A61P39/00" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P39/00</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>General protective or antinoxious agents</text></title-part></class-title>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P39/02" definition-exists="false" ipc-concordant="A61P39/02" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P39/02</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Antidotes</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P39/04" definition-exists="false" ipc-concordant="A61P39/04" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P39/04</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Chelating agents</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="8" additional-only="false" sort-key="A61P39/06" definition-exists="false" ipc-concordant="A61P39/06" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P39/06</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Free radical scavengers or antioxidants</text></title-part></class-title></classification-item></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="7" additional-only="false" sort-key="A61P41/00" definition-exists="true" ipc-concordant="A61P41/00" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P41/00</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution</text></title-part></class-title></classification-item>
|
|
<classification-item breakdown-code="false" not-allocatable="false" level="7" additional-only="false" sort-key="A61P43/00" definition-exists="true" ipc-concordant="A61P43/00" c-set-base-allowed="false" c-set-subsequent-allowed="true" date-revised="2018-01-01" status="published"><classification-symbol>A61P43/00</classification-symbol><class-title date-revised="2018-01-01"><title-part><text>Drugs for specific purposes, not provided for in groups <class-ref scheme="cpc">A61P1/00</class-ref>-<class-ref scheme="cpc">A61P41/00</class-ref></text></title-part></class-title><notes-and-warnings><note type="note"><note-paragraph>Classification is only made in this group when a specific therapeutic activity for a chemical compound or medicinal preparation has been clearly disclosed, the specific therapeutic activity not being appropriate to any of groups <class-ref scheme="cpc">A61P1/00</class-ref> - <class-ref scheme="cpc">A61P41/00</class-ref>. </note-paragraph></note></notes-and-warnings></classification-item></classification-item></classification-item></class-scheme> |